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Abstract
Background: Naswar is a type of finely ground, moistened smokeless dipping tobacco product being commonly
used in Pakistan. Although, nicotine is the most important psychoactive agent present in Naswar, it also exerts
immunosuppressive effects and could alter the levels of cytokines. Additionally, the effects of Naswar consumption
on thyroid hormones are not known.
Methods: Eighty healthy males aged 16–43 years were selected for the study and were divided into a control
group comprising 31 healthy subjects with no history of tobacco use in any form, with age matched test group
comprising 49 exclusive Naswar users who were consuming Naswar for at least 1 year. Estimation of serum
interleukin (IL)-1β, IL-6, free thyroxine (FT4), free triiodothyronine (FT3) and thyroid stimulating hormone (TSH)
was carried out. The data was analyzed by statistical programme (SPSS) using student's independent samples
t-test. One way Anova followed by post hoc Tukey test was applied to assess parameters in Naswar users grouped
according to duration of Naswar usage. Pearson’s correlation coefficient was applied to assess correlations between
parameters.
Results: IL-1β was found to be significantly lowered in Naswar users compared to the control group whereas
serum FT3 and FT4 levels in Naswar users were significantly raised compared to the control group. However, no
differences in the levels of serum IL-6 and TSH between Naswar users and the control group were found. Also,
serum FT3 and FT4 were consistently raised whereas IL-1β was lowered in Naswar users irrespective of duration
of Naswar consumption. IL-1β was negatively correlated with FT3 in Naswar users.
Conclusion: The findings suggest that Naswar users might be in an immune suppressive state as evident by the
lowered levels of interleukin 1β. Additionally, alterations in the levels of thyroid hormones signify the impact of
Naswar consumption on thyroid function.
Keywords: Smokeless tobacco, Naswar, Interleukins, Free triiodothyronine, Free thyroxine, Thyroid stimulating
hormone
Background
Naswar (sometimes also called niswar) is a dipping
smokeless tobacco product commonly used in Pakistan,
India, Iran, Afghanistan and in South Africa [1]. In
Pakistan, it is widely used by the Pushton ethnic group
where it constitutes an integral part of their cultural
heritage being considered completely harmless. The sun-
dried tobacco leaves, belonging to Nicotina rustica
species, are finely ground and then mixed with calcium
oxide and wood ash. Flavorings such as cardamom,
menthol and coloring agents such as indigo are also
added. These ingredients are placed in a cement-lined
cavity and pounded with a weighty wooden hammer.
After addition of water, the material is rolled into balls.
Packed in small polythene bags, the size of tea bags, a
pinch of Naswar (about 1 g) is placed between cheek
and gum several times during the course of the day for
about 30 min before being spat out [2].* Correspondence: faizataha@gmail.com
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Naswar has been implicated in the causation of oral
cavity and esophageal cancers [3]. It contains increased
concentrations of oncogenic substances such as nitrosa-
mines and various toxic metals including cadmium, ar-
senic, lead and chromium [2]. Exposure to smokeless
tobacco (ST) causes systemic absorption of various toxic
metals [4] that might cause altered levels of cytokines.
Cytokines are low-molecular-weight proteins that are se-
creted by lymphocytes and macrophages [5] and could
be broadly classified into two major types namely the
pro inflammatory and the anti-inflammatory cytokines.
The pro inflammatory cytokines as the name suggests
are involved in inflammatory processes for eg Interleu-
kin (IL)-1, IL-6, interferon (IFN)- γ and tumor necrosis
factor(TNF)-α whereas the anti-inflammatory interleu-
kins for e.g., IL-13, IL-10 and IL-4, inhibit the immune
response and also decrease the production of pro in-
flammatory cytokines. Cadmium chloride at low concen-
trations causes increased concentrations of mRNA
forIL-1α, IL-1β, IL-8, TNFα as well as for IL-6 but at
higher concentrations, it causes depression of the accu-
mulation of mRNA for IL-1α, IL-1β and TNFα but not
for IL-6 and IL-8 [6].
Tobacco smoking exerts an inflammatory effect on al-
veolar macrophages leading to the production of proin-
flammatory cytokines such as IL-6 and IL-1β [7, 8].
However, although the harmful effects of tobacco smoke
are avoided in smokeless tobacco products, the presence
of nicotine in Naswar [2] could cause alterations in the
levels of cytokines as nicotine has been to shown to
exert immunosuppressive effects [9]. The nicotinic
acetylcholine receptor-α7 (α7nAChR) subunit inhibits
the synthesis of pro inflammatory cytokine by choliner-
gic anti- inflammatory pathway, the latter being involved
in immune response [10]. A study that evaluated sys-
temic immune markers involved in inflammation and
immunity showed decreased levels of seven markers of
inflammation including proinflammatory (IL-1β) and
anti-inflammatory cytokines (IL-1Ra) in current smokers
compared to non-smokers [11]. Additionally several other
studies have also shown the association of cigarette
smoking with increased levels of C-reactive protein and
decreased levels of IL-1β in vitro and in animal models
[12–15] thus emphasizing immuno-supppressive effects of
cigarette smoking on the cytokines and in turn pointing
towards immune-suppressive effects of nicotine [16].
However, the effect of Naswar consumption on systemic
proinflammatory interleukins is not known.
Several studies indicate that smokers exhibit a de-
creased risk of developing thyroid peroxidase and
thyroglobulin antibodies and are protected against
autoimmune hypothyroidism [17–20]. Acting via α7-
nicotinic-acetylcholine receptor (nAChR), nicotine in-
creases the T-mediated immune suppression of
lymphocytes. Nicotine has also been shown to alter the
autoimmune profile from pathogenic Th 1 and Th17
responses to protective Th 2 response. On the other
hand, smokers have also been shown to be at an in-
creased risk of developing Graves ophthalmopathy [21]
and that in turn might be mediated by Th 2 responses
[22]. Additionally, the presence of various toxins such
as thiocyanate could also be one of the causes of devel-
opment of graves ophthalmopathy in cigarette smokers
[23]. However, the effects of smokeless tobacco con-
sumption on thyroid hormone levels are not known.
With this background, the present study was designed
to evaluate the circulatory levels of proinflammatory
markers in relation to Naswar consumption. Addition-
ally, the levels of thyroid hormones were also deter-
mined in order to ascertain the endocrine effect of
nicotine in the smokeless tobacco. Additionally, as pro-
inflammatory cytokines have been shown to influence
thyroid function [24] any association between IL-1β and




Eighty healthy male subjects aged 16–43 years were re-
cruited for this case control study, following written, in-
formed consent. Females were excluded as Naswar is
predominantly used by the male pushtoon ethnic group
and is rarely used by the females in Pakistan.
Subjects were divided into a control group comprising
31 healthy subjects with no history of tobacco use in any
form, with age matched test group comprising 49 exclu-
sive Naswar users who were consuming Naswar for at
least 1 year. Subjects with history of tobacco usage other
than Naswar were excluded from the test group.
Additionally, subjects suffering from diabetes mellitus,
obesity, cardiovascular, pulmonary or renal disorders or
taking any antioxidant vitamin supplements were also
excluded from the study. Ethical approval was obtained
from the institutional ethical committee at the Univer-
sity of Karachi.
To assess the impact of duration of Naswar usage,
Naswar users were further subdivided into three
groups: Group 1: Subjects using Naswar for a dur-
ation of <5 years (n = 15), Group 2: Subjects using
Naswar for duration of 6–10 years (n = 13) and Group
3: Subjects using Naswar for a duration of >10 years
(n = 21). A questionnaire was filled to obtain informa-
tion on age, occupational history, duration and fre-
quency of Naswar usage.
Samples
Ten milliliter of venous blood was drawn from the ante-
cubital vein under aseptic conditions after 12 h fast in
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vacutainers containing no additives. The blood was
allowed to clot and serum separated within 30 min after
centrifuging at 3000 rpm for 10 min and aliquots were
stored at −20 °C.
Laboratory measurement
IL-6 and IL-1ß were quantified by enzyme-linked im-
munosorbent assay (ELISA) (ABCAM catalogue number
ab46027 and ab46052 respectively). The lower limits of
detection of the kits (supplier's data) were as follows: IL-
1β, 6.5 pg · mL-1; IL-6, 2 pg · mL-1; Samples with con-
centrations of IL-1β below the limit of detection were
assigned a cytokine concentration value that was one
half of the lower limit of detection rather than a zero
value. IL-6 concentrations were above the lower limit of
detection in all samples. FT3, FT4 and TSH were deter-
mined by enzyme-linked immunosorbent assay (ELISA)
(Biocheck catalogue number BC-1006, BC-1008, BC1001
respectively). According to kits’ manufacturer, normal
reference range for FT3 is 1.4–4.2 pg/ml, for FT4
0.8–2.0 ng/dl and for TSH in adults 21–54 years is
0.4–4.2μU/ml.
Statistical analysis
The data was analyzed by statistical programme (SPSS)
using student's independent samples t-test. One way
Anova followed by post hoc Tukey test was applied to
assess parameters in Naswar users grouped according to
duration of Naswar usage. Pearson’s correlation coeffi-
cient was applied to assess correlations between parame-
ters. P <0.05 was considered as statistically significant.
Results
Effect of Naswar usage on proinflammatory interleukins
and thyroid function
IL-1β was found to be significantly lowered in Naswar
users compared to the control group (p < 0.0001). On
the other hand, no difference in the levels of serum IL-6
between Naswar users and the control group were
found. Additionally, both FT3 and FT4 were significantly
raised in Naswar users compared to the control group
(p < 0.001) whereas no significant difference in the levels
of TSH between Naswar users and the control group
was found (Table 1).
Effects of Naswar usage on pro inflammatory interleukins
and thyroid function in Naswar users grouped according
to duration of its usage
Serum IL-1β levels were found to be significantly low-
ered in all the three groups of Naswar users compared
to the control group whereas no significant difference
between the levels of IL-6 in all the three groups of
Naswar users versus the control group was depicted.
Both FT3 and FT4 were consistently raised in all the
three groups of Naswar users as compared to controls.
No significant difference in serum TSH was found in
any of the three groups as compared to control
(Table 2).
Correlations between IL-1β and IL-6 versus FT3, FT4 and
TSH in Naswar users
FT3 was found to be significantly inversely related to
serum IL-1β in Naswar users (Fig. 1) whereas no other
significant correlations were depicted.
Discussion
In the present study, various parameters related to the
endocrinological and inflammatory responses in Naswar
users were evaluated.
IL-1β was found to be significantly decreased in
Naswar users compared to the controls whereas no dif-
ference in the levels of IL-6 between Naswar users and
controls was found. These findings might be attributed
to the immuno suppressant effects of nicotine present in
Naswar as nicotine has been shown to exert an inhibi-
tory effect on the release of the pro inflammatory cyto-
kines IL-1β and IL-6 [25] as is also reflected by
persistently decreased levels of IL-1β in Naswar users re-
gardless of duration of Naswar consumption.
This is the first study evaluating the serum levels of
IL-1β and IL-6 in Naswar users. However, a study con-
ducted on mice showed increased plasma levels of IL-6
and IL-1β following an intra cerebroventricular injection
of low dose nicotine. However, the maximum doses of
peripherally administered nicotine failed to produce such
a response [26]. Another study conducted on alveolar
macrophages of chronic smokers has shown a defect in
the release but not production of IL-1 from the alveolar
macrophages [27]. Further, a study on an aqueous ex-
tract of smokeless tobacco showed increased production
of TNF α and IL-1β following low doses of the extract
[28]. Additionally, another study showed consistently
raised levels of IL-6, IL-1β and platelet derived growth
Table 1 Effect of Naswar on proinflammatory interleukins and
thyroid function
Controls Naswar Users
N = 31 N = 49
IL-1β (pg/ml) 24.19 ± 0.73 16.27 ± 1.22 **
IL-6 (pg/ml) 7.69 ± 0.70 10.62 ± 1.17 NS
FT4 (ng/dl) 1.79 ± 0.09 3.63 ± 0.06*
FT3 (pg/ml) 2.20 ± 0.15 4.76 ± 0.37*
TSH (μU/mL) 2.05 ± 0.21 1.60 ± 0.15 NS
Experimental details are given in Methods section. Values are mean ± SEM.
Statistical analysis was performed using student’s t-test. The significance of
the difference is indicated by *p < 0.001 and **p < 0.0001 from controls
NS non-significant, IL interleukin, FT3 free triiodohyronine, FT4 free thyroxine,
TSH thyroid stimulating hormone
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factor in the alveolar cells that were stimulated by anti-
gen present in tobacco leaves [29]. Also, an imbalance in
the circulating levels of interleukins in tobacco smokers
has been reported and studies have shown significantly
increased levels of plasma IL-6 in smokers compared to
non-smokers [7, 8, 30].
Conversely, a study conducted on cigarette smoke ex-
tract to evaluate the levels of cytokines showed inhib-
ition of TNF alpha, IFN-gamma, IL-2 and IL-1β
indicating the presence of inhibitors of cytokine produc-
tion in the extract [14]. Various studies have also shown
decreased levels of various pro inflammatory cytokines
in gingival clevicular fluid of smokers [31, 32].
The present study showed increased levels of FT4 and
FT3 concentrations as compared to controls, whereas
no difference between the levels of TSH in controls and
Naswar users was found. However, the levels of TSH in
Naswar users were on the lower limit of the normal
range. We found no study depicting the levels of thyroid
hormones in Naswar or any other smokeless tobacco
product. However, there are studies evaluating thyroid
hormone levels in cigarette smokers who have been
reported to suffer from lowered TSH levels and raised
T3 and T4 levels as compared to non-smokers [33].
Similar findings have been reported in passive smokers
also [20]. Another study reported higher free T4 and free
T3 levels as well as low TSH levels in smokers compared
to non-smokers [34]. Low TSH levels in smokers have
been reported in various other studies also [18, 35].
Additionally, Balhara and Deb reviewed the effects of to-
bacco on thyroid function and concluded that almost all
functions of the thyroid gland are affected by tobacco
smoking [36]. Thus, it could be inferred that nicotine ex-
erts a stimulatory effect on the release of thyroid hor-
mones thereby suppressing the release of TSH [19]. On
the contrary, various studies have shown no relation be-
tween the levels of serum TSH and smoking [37–39].
Although, cytokines can also be produced by thyroid
gland, they also target it resulting in disease [40] and in-
creased levels of cytokines such as IL-6 and IL-1β have
been associated with lowered T3 and T4 levels in non-
thyroidal illnesses [41]. IL-1β down regulates the synthe-
sis of thyroglobulin [42] and Thyroid peroxidase [43]
and also causes inhibition of iodide organification [44]
thereby leading to decreased thyroid hormone levels [45,
46]. Correlation between FT3, FT4 and TSH versus in-
terleukins was determined in the present study in order
to evaluate any association between Hypothalamic Pitu-
itary Thyroid axis and interleukins in relation to Naswar
consumption. A significant inverse correlation between
FT3 and IL-1β in Naswar users was found that
might reflect the effect of nicotine on thyroid hor-
mones and interleukins. No association found be-
tween FT3, FT4, TSH versus IL-6 might be due to
the normal levels of latter.
Conclusion
Lowered levels of interleukin 1β in Naswar users indi-
cate immunosuppressant effects of nicotine present in
Naswar. In addition to this, raised levels of free T3 and
free T4 in Naswar users, which although were in the
Table 2 Pro inflammatory interleukins and thyroid function in Naswar users grouped according to duration of its usage
Controls Naswar users grouped according to duration of Naswar usage
<5 years 6–10 years >10 years
N 31 15 13 21
Interleukin 1β (pg/ml) 24.19 ± 0.73 13.46 ± 2.16* 15.29 ± 3.19* 17.62 ± 1.63*
Interleukin 6 (pg/ml) 7.69 ± 0.70 12.93 ± 3.24 7.03 ± 0.77 10.45 ± 1.32 NS
FT3 (pg/ml) 2.20 ± 0.15 5.34 ± 0.65** 4.31 ± 1.0 4.81 ± 0.49**
FT4 (ng/dl) 1.79 ± 0.09 3.42 ± 0.07** 3.91 ± 0.18 3.66 ± 0.08**
TSH (μU/mL) 2.05 ± 0.21 1.52 ± 0.17 NS 1.36 ± 0.24 NS 1.81 ± 0.31 NS
Experimental details are given in Methods section. Values are mean ± SEM. Statistical analysis was performed using one-way ANOVA followed by post hoc Tukey’s
test. The significance of the difference is indicated by *p < 0.05 and **p < 0.01 from controls
NS non-significant, FT3 free triiodohyronine, FT4 free thyroxine, TSH thyroid stimulating hormone
Fig. 1 Correlation between IL-1β versus FT3 in Naswar users.
FT3 = free triiodothyronine, IL = Interleukin. *Correlation is
significant at the 0.01 level
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upper limit of normal, depict the altered effects of Nas-
war usage on thyroid function.
Abbreviations
FT3, free triiodothyronine; FT4, free thyroxine; IL, interleukin; TSH, thyroid
stimulating hormone
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